title: Muscarinic properties of compounds related to arecaidine propargyl ester.
abstract: A series of new analogues of the arecaidine propargyl ester (CAS 35516-99-5), APE, 1a) with alcohols consisting of 4 or 5 carbon atoms were investigated at muscarinic receptor subtypes. The muscarinic activity of the quaternary and tertiary salts of the APE-related compounds were assayed on the isolated guinea-pig ileum (M3 receptor subtype) and guinea-pig left atria (M2 receptor subtype) as well as on rabbit isolated vas deferens (M1 receptor subtype). The structural variations made in the APE molecule, replacing the triple bond in the ester side chain with structures such as double bond, an allene moiety, a single bond, a cyclopropyl group or two triple bonds should alter the selectivity and potency in favour of the M2 subtype. Enhanced, though modest, selectivity for M2 receptors was achieved with the 2-butynyl ester 2a. The other structural variations resulted in a loss of potency, but not necessarily of efficacy.
authors.affiliation: Department of Pharmaceutical Sciences, University of Bologna, Italy. tumiatti@alma.unibo.it
authors.forename: V
authors.initials: V
authors.lastname: Tumiatti
authors.forename: J
authors.initials: J
authors.lastname: Wehrle
authors.forename: C
authors.initials: C
authors.lastname: Hildebrandt
authors.forename: U
authors.initials: U
authors.lastname: Moser
authors.forename: G
authors.initials: G
authors.lastname: Dannhardt
authors.forename: E
authors.initials: E
authors.lastname: Mutschler
authors.forename: G
authors.initials: G
authors.lastname: Lambrecht
mesh_terms: D000818:Animals; D001115:Arecoline / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D018678:Cholinergic Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D011817:Rabbits; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D011976:Receptors, Muscarinic / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
chemical_list: D018678:Cholinergic Agents; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D011976:Receptors, Muscarinic; C015000:arecaidine esters; D001115:Arecoline